Unverified dose status: Additional teaching points are not a substitute for drug- and indication-specific BNF/BNFC, local formulary and pharmacist review; independent sign-off remains outstanding (4 November 2026).
Narrow therapeutic window; check eGFR, thyroid, sodium and interacting NSAIDs/ACEi/diuretics
โ ๏ธ Main safety issue / monitoring
Toxicity with dehydration and renal decline
๐งช Mandatory prescription check: identity, indication, dose, route, formulation, age/weight, allergies, renal/hepatic function, pregnancy, interactions, time of last dose and required observations.
Do not use this card for dosing. Verify the current BNF/BNFC, MedicinesComplete and local NHS formulary before every prescription. For specialist/high-risk drugs use local clinical protocols and pharmacist or consultant review.